灵芝产业

Search documents
中国中药协会灵芝专业委员会2025年会在冠县举办
Qi Lu Wan Bao Wang· 2025-06-06 01:57
Group 1 - The conference on the high-quality development of the Ganoderma industry was held in Guancun County, Shandong, with over 110 experts and representatives from academia and industry attending [1] - The China Ganoderma Association officially released the "China Ganoderma Industry Integrity Convention" to maintain market order and promote sustainable development [2] - Guancun County has become the largest Ganoderma cultivation and trading base in China, with over 10,000 acres of cultivation and an annual production of over 15,000 tons of fruiting bodies and spores [2] Group 2 - The conference featured reports from industry leaders and researchers on topics such as brand trust, cultivation techniques, and pharmacological studies related to Ganoderma [3] - The local government aims to develop the Ganoderma industry into a 10 billion yuan industry cluster, integrating various sectors and enhancing the value chain [3]
艾瑞咨询授予华弘草芝堂“中国深山林下林芝第一品牌”等认证
艾瑞咨询· 2025-05-30 09:15
Core Viewpoint - Huahong Caizhitang has been recognized as the "No. 1 Brand of Deep Mountain Ganoderma in China" and is projected to achieve the highest sales of deep mountain Ganoderma in 2024, establishing its leading position in the industry [1][12]. Industry Overview - The Ganoderma industry in China has developed a comprehensive supply chain from breeding and cultivation to processing and sales, showing a trend of scale development. China is home to 124 known species of Ganoderma, accounting for 88% of the world's known varieties, which provides a core advantage in variety cultivation [9]. - As of 2023, over 300 companies are engaged in the cultivation, production, and sales of Ganoderma, with an annual production of approximately 137,000 tons [9]. - The focus of the industry is on the deep development of Ganoderma spore powder, utilizing advanced extraction technologies to create a mature product line that includes capsules, slices, and spore oil, which are becoming mainstream in the health food market [9]. Company Profile - Huahong Caizhitang has a cultivation history dating back to 1992, with a core team that pioneered deep mountain Ganoderma and spore powder in China. The company cultivates Ganoderma at an altitude of 1,200 meters in Guizhou, using ecological cultivation techniques [11]. - The company has developed a complete supply chain from breeding, research and development to production and sales, offering over 10 products across three main series: tea soup health, high-end nourishment, and ultimate health [12]. - Huahong Caizhitang's spore powder is derived from deep mountain Ganoderma, ensuring high nutritional content and quality, which has led to its recognition as the top brand in the industry [12].
山东泰山灵芝集团战略沟通会隆重召开,提升患者整体福祉!
Zhong Guo Shi Pin Wang· 2025-05-24 11:09
Core Viewpoint - The health and wellness industry is focusing on enhancing patient well-being, with Shandong Taishan Ganoderma Group actively participating in this mission through strategic initiatives and collaborations [1][3]. Group 1: Achievements in Patient Well-being - Over the past year, Shandong Taishan Ganoderma Group has made significant progress in enhancing patient well-being through increased investment in product research and development, collaborating with renowned universities and research institutions [3]. - The company’s health technology division has been recognized as a key project for green, low-carbon, and high-quality development in Shandong Province, highlighting its commitment to sustainable practices [3]. - The modern factory located at the foot of Mount Tai features a 4,000 square meter transparent, visible, and ten-thousand-level purification workshop, adhering to GMP standards to ensure product quality and safety [3]. - The factory is expected to achieve an annual production capacity of 150 tons of broken spore powder and 300 tons of ganoderma extract, significantly enhancing market supply capabilities [3]. Group 2: Future Development Plans - The chairman of Shandong Taishan Ganoderma Group outlined the 2025 work priorities, focusing on deepening research into the medicinal value of ganoderma and accelerating the development of new products targeting chronic diseases and immune enhancement [4]. - The company plans to optimize production processes by introducing intelligent management systems to improve efficiency, product quality stability, and reduce production costs, making high-quality ganoderma products more affordable for patients [4]. - The company aims to uphold the philosophy of "inheriting the thousand-year ganoderma culture and innovating the modern health industry," emphasizing technological advancement, market orientation, and patient well-being [4].